ArticleInternational journal of hematology2020

Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myeloma.

Isamu Sugiura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.